Seeking Alpha

Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine...

Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine extended-release tablets, a generic version of AstraZeneca's (AZN +0.3%) Plendil blood pressure medication.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector